Concepedia

Hirofumi Ando

HA

Statistics

Publications

12

Citations

394

H-Index

11

Active since

1996

Affiliations

Shinshu University(Current)

Teikyo University

Hirofumi Ando is an author at Shinshu University specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

1996–2022

12

Publications

12

Sirtuin 1 promotes the growth and cisplatin resistance of endometrial carcinoma cells: a novel therapeutic target

Ryoichi Asaka, Tsutomu Miyamoto, Yasushi Yamada et al. · Laboratory Investigation · 2015 · 93 citations · Full text

, , +15

SIRT1 Regulates the Chemoresistance and Invasiveness of Ovarian Carcinoma Cells

David Hamisi Mvunta, Tsutomu Miyamoto, Ryoichi Asaka et al. · Translational Oncology · 2017 · 47 citations · Full text

, , +17

Overexpression of SIRT1 is Associated With Poor Outcomes in Patients With Ovarian Carcinoma

David Hamisi Mvunta, Tsutomu Miyamoto, Ryoichi Asaka et al. · Applied immunohistochemistry & molecular morphology · 2016 · 44 citations

, , +13

Lipocalin 2 Enhances Migration and Resistance against Cisplatin in Endometrial Carcinoma Cells

Tsutomu Miyamoto, Hiroyasu Kashima, Yasushi Yamada et al. · PLoS ONE · 2016 · 37 citations · Full text

, , +11

Lipocalin 2 attenuates iron-related oxidative stress and prolongs the survival of ovarian clear cell carcinoma cells by up-regulating the CD44 variant

Yasushi Yamada, Tsutomu Miyamoto, Hiroyasu Kashima et al. · Free Radical Research · 2016 · 34 citations

, , +17

1–5 of 12